Novo Nordisk A/S (NVO) stock analysis

In our weekly check, Novo Nordisk A/S is graded B (A to F). Of 21 checks on debt, profit, cash flow and trend: 16 pass, warnings: 4, red flags: 1.

Sector: Healthcare · Drug Manufacturers - General

Strengths

• Easily covers interest
• Margins rising
• High margins
• Strong free cash flow
• High return on capital

Warning signs

• Gross margin falling
• Dividend stretched

Next earnings report: 2026-11-04

Similar companies

PFE · GILD · AMGN · BMY · AZN · NVS

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks graded D or F lost a third of their value 2-3 times as often as those graded A or B.

Updated 2026-10-03

Open the full analysis